Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Cyst
ADR ID BADD_A01139
ADR Hierarchy
08      General disorders and administration site conditions
08.03      Tissue disorders NEC
08.03.05      Mass conditions NEC
08.03.05.001      Cyst
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.02      Miscellaneous and site unspecified neoplasms benign
16.02.02      Neoplasms benign site unspecified NEC
16.02.02.002      Cyst
Description Any fluid-filled closed cavity or sac that is lined by an EPITHELIUM. Cysts can be of normal, abnormal, non-neoplastic, or neoplastic tissues. [MeSH]
MedDRA Code 10011732
MeSH ID D003560
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Cyst | Cyst NOS | Retention cyst | Oil cyst | Cysts
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01777Pioglitazone--
BADD_D01786Pixantrone--
BADD_D01798Pomalidomide0.005211%
BADD_D01803Porfimer sodium--
BADD_D01834Prednisone0.000060%
BADD_D01835Pregabalin--
BADD_D01906Raltegravir potassium--
BADD_D01916Rasagiline mesylate--
BADD_D01922Regorafenib--
BADD_D01933Ribavirin--
BADD_D01942Riluzole--
BADD_D01943Rimabotulinumtoxinb--
BADD_D01950Risedronic acid--
BADD_D01989Saquinavir mesylate--
BADD_D02002Selegiline--
BADD_D02007Semaxanib--
BADD_D02028Sirolimus--
BADD_D02029Sitagliptin0.000375%
BADD_D02031Sitaxentan--
BADD_D02047Sodium oxybate0.001817%
BADD_D02058Sorafenib0.000533%
BADD_D02098Sumatriptan--
BADD_D02100Sunitinib0.001598%
BADD_D02104Tacrine hydrochloride--
BADD_D02105Tacrolimus--
BADD_D02112Tamoxifen citrate--
BADD_D02140Tegaserode--
BADD_D02150Temozolomide0.001066%
BADD_D02165Teriflunomide0.001737%
BADD_D02170Testosterone--
The 4th Page    First    Pre   4 5    Next   Last    Total 5 Pages